Speakers
Max Jaderberg is the President of Isomorphic Labs, an AI company developing and applying frontier AI to reimagine and advance the drug design process from first principles. Learn more.
Andreas Bender is a Professor for Machine Learning in Medicine at the Department of Medicine at Khalifa University, Abu Dhabi. Learn more.
Connor W. Coley is an associate professor at MIT in the Department of Chemical Engineering and the Department of Electrical Engineering and Computer Science. Learn more.
Ron Dror is the Cheriton Family Professor of Computer Science in the Stanford Artificial Intelligence Lab and a professor, by courtesy, of Structural Biology and of Molecular and Cellular Physiology at the Stanford School of Medicine. He leads a research group that uses molecular simulation and machine learning to elucidate biomolecular structure, dynamics, and function, and to guide the development of more effective medicines. Learn more.
Hoifung Poon is Chief AI Officer at Recursion, responsible for the company's end-to-end AI strategy and execution across drug discovery and clinical development. Hoifung is a globally recognized leader in biomedical AI, working at the intersection of frontier AI research and real-world applications in biology and medicine. Learn more.
Pat Walters is the Chief Scientist at OpenADMET, an open-science initiative integrating high-throughput experimentation, structural biology, and machine learning to advance ADMET prediction. Alongside his work at OpenADMET, he serves as an Adjunct Professor in the Department of Bioengineering & Therapeutic Sciences at UCSF. Learn more.
Bo Wang is Co-Founder and Chief AI Scientist at Xaira Therapeutics, where he leads the development of next-generation AI for biology and drug discovery. He is also a professor at the University of Toronto and a CIFAR AI Chair at the Vector Institute. Learn more.
